1-9 of 9
Klaus Rave
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: A proof-of-concept study

Sabine Arnolds, MD, Sibylle Dellweg, MD, Janina Clair, MD, Marie-Paule Dain, MD, Michael A. Nauck, MD, Klaus Rave, MD, Christoph Kapitza, MD
Journal: Diabetes Care
Diabetes Care 2010;33(7):1509–1515
https://doi.org/10.2337/dc09-2191
Published: 31 March 2010
View article titled, Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: <subtitle>A proof-of-concept study</subtitle>
Open the PDF for Further Improvement in Postprandial Glucose Control With Addition of Exenatide or Sitagliptin to Combination Therapy With Insulin Glargine and Metformin: <subtitle>A proof-of-concept study</subtitle> in another window
Journal Articles

Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes

Reinhard H.A. Becker, MD, Annke D. Frick, PHD, Leszek Nosek, MD, Lutz Heinemann, PHD, Klaus Rave, MD
Journal: Diabetes Care
Diabetes Care 2007;30(10):2506–2507
https://doi.org/10.2337/dc06-2114
Published: 01 October 2007
View article titled, Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes
Open the PDF for Dose-Response Relationship of Insulin Glulisine in Subjects With Type 1 Diabetes in another window
Journal Articles

Coverage of Postprandial Blood Glucose Excursions With Inhaled Technosphere Insulin in Comparison to Subcutaneously Injected Regular Human Insulin in Subjects With Type 2 Diabetes

Klaus Rave, MD, Tim Heise, MD, Andreas Pfützner, MD, PHD, Anders H. Boss, MD, MFPM
Journal: Diabetes Care
Diabetes Care 2007;30(9):2307–2308
https://doi.org/10.2337/dc07-0478
Published: 01 September 2007
View article titled, Coverage of Postprandial Blood Glucose Excursions With Inhaled Technosphere Insulin in Comparison to Subcutaneously Injected Regular Human Insulin in Subjects With Type 2 Diabetes
Open the PDF for Coverage of Postprandial Blood Glucose Excursions With Inhaled Technosphere Insulin in Comparison to Subcutaneously Injected Regular Human Insulin in Subjects With Type 2 Diabetes in another window
Journal Articles

AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease: Pharmacokinetics, glucodynamics, safety, and tolerability

Klaus Rave, MD, Amparo de la Peña, PHD, Fabián S. Tibaldi, PHD, Liping Zhang, PHD, Bernard Silverman, MD, Michaela Hausmann, MD, Lutz Heinemann, PHD, Douglas B. Muchmore, MD
Journal: Diabetes Care
Diabetes Care 2007;30(7):1777–1782
https://doi.org/10.2337/dc06-2284
Published: 01 July 2007
View article titled, AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease: <subtitle>Pharmacokinetics, glucodynamics, safety, and tolerability</subtitle>
Open the PDF for AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease: <subtitle>Pharmacokinetics, glucodynamics, safety, and tolerability</subtitle> in another window
Journal Articles

Advantage of Premeal-Injected Insulin Glulisine Compared With Regular Human Insulin in Subjects With Type 1 Diabetes

Klaus Rave, MD, Oliver Klein, MD, Annke D. Frick, PHD, Reinhard H.A. Becker, MD
Journal: Diabetes Care
Diabetes Care 2006;29(8):1812–1817
https://doi.org/10.2337/dc06-0383
Published: 01 August 2006
View article titled, Advantage of Premeal-Injected Insulin Glulisine Compared With Regular Human Insulin in Subjects With Type 1 Diabetes
Open the PDF for Advantage of Premeal-Injected Insulin Glulisine Compared With Regular Human Insulin in Subjects With Type 1 Diabetes in another window
Journal Articles

Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes

Thomas Danne, MD, Reinhard H. A. Becker, MD, Tim Heise, MD, Claudia Bittner, MD, Annke D. Frick, PHD, Klaus Rave, MD
Journal: Diabetes Care
Diabetes Care 2005;28(9):2100–2105
https://doi.org/10.2337/diacare.28.9.2100
Published: 01 September 2005
View article titled, Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes
Open the PDF for Pharmacokinetics, Prandial Glucose Control, and Safety of Insulin Glulisine in Children and Adolescents With Type 1 Diabetes in another window
Journal Articles

Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin

Klaus Rave, MD, Susanne Bott, MD, Lutz Heinemann, PHD, Sue Sha, MD, PHD, Reinhard H.A. Becker, MD, PHD, Susan A. Willavize, PHD, Tim Heise, MD
Journal: Diabetes Care
Diabetes Care 2005;28(5):1077–1082
https://doi.org/10.2337/diacare.28.5.1077
Published: 01 May 2005
View article titled, Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin
Open the PDF for Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin in another window
Journal Articles

Effect of C-Peptide on Glucose Metabolism in Patients With Type 1 Diabetes

Thomas Forst, Klaus Rave, Andreas Pfuetzner, Ronald Buchholz, Thomas Pohlmann, Mirjam Löbig, Lutz Heinemann
Journal: Diabetes Care
Diabetes Care 2002;25(6):1096–1097
https://doi.org/10.2337/diacare.25.6.1096
Published: 01 June 2002
View article titled, Effect of C-Peptide on Glucose Metabolism in Patients With Type 1 Diabetes
Open the PDF for Effect of C-Peptide on Glucose Metabolism in Patients With Type 1 Diabetes in another window
Journal Articles

Impact of Diabetic Nephropathy on Pharmacodynamic and Pharmacokinetic Properties of Insulin in Type 1 Diabetic Patients

Klaus Rave, Tim Heise, Andreas Pfützner, Lutz Heinemann, Peter T. Sawicki
Journal: Diabetes Care
Diabetes Care 2001;24(5):886–890
https://doi.org/10.2337/diacare.24.5.886
Published: 01 May 2001
View article titled, Impact of Diabetic Nephropathy on Pharmacodynamic and Pharmacokinetic Properties of Insulin in Type 1 Diabetic Patients
Open the PDF for Impact of Diabetic Nephropathy on Pharmacodynamic and Pharmacokinetic Properties of Insulin in Type 1 Diabetic Patients in another window